46 related articles for article (PubMed ID: 21450501)
1. Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults.
Murray RD; Randeva HS; Lewandowski KC; Komorowski J; Lawrance JA; Adams JE; Shalet SM
Growth Horm IGF Res; 2011 Apr; 21(2):96-101. PubMed ID: 21450501
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals.
Randeva HS; Lewandowski KC; Komorowski J; Murray RD; O'Callaghan CJ; Hillhouse EW; Stepien H; Shalet SM
Circulation; 2004 May; 109(20):2405-10. PubMed ID: 15123527
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs.
Gentilini F; Calzolari C; Turba ME; Agnoli C; Fava D; Forni M; Bergamini PF
Leuk Res; 2005 Nov; 29(11):1263-9. PubMed ID: 15893373
[TBL] [Abstract][Full Text] [Related]
4. [Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency].
Szczepańska-Kostro J; Kowalewski M; Urban M; Gardziejczyk M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):257-60. PubMed ID: 17239302
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
6. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
7. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
8. The effects of growth hormone status on circulating levels of vascular growth factors.
Silha JV; Krsek M; Hana V; Marek J; Weiss V; Jezkova J; Rosicka M; Jarkovska Z; Murphy LJ
Clin Endocrinol (Oxf); 2005 Jul; 63(1):79-86. PubMed ID: 15963066
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Laack E; Scheffler A; Burkholder I; Boeters I; Andritzky B; Schuch G; Görn M; Vohwinkel G; Edler L; Fiedler W; Hossfeld DK
Lung Cancer; 2005 Oct; 50(1):51-8. PubMed ID: 15992959
[TBL] [Abstract][Full Text] [Related]
11. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Yildiz B; Kural N; Colak O; Ak I; Akcar N
Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
[TBL] [Abstract][Full Text] [Related]
12. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
de Boer H; Blok GJ; Popp-Snijders C; Sips A; Lips P; van der Veen E
J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
[TBL] [Abstract][Full Text] [Related]
13. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
[TBL] [Abstract][Full Text] [Related]
14. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
[TBL] [Abstract][Full Text] [Related]
15. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
16. Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement.
Lewandowski KC; Murray RD; Drzewoski J; O'Callaghan CJ; Czupryniak L; Hillhouse EW; Shalet SM; Randeva HS
Mol Genet Metab; 2003 Nov; 80(3):330-7. PubMed ID: 14680980
[TBL] [Abstract][Full Text] [Related]
17. GH replacement reduces increased lipid peroxidation in GH-deficient adults.
Karbownik-Lewinska M; Kokoszko A; Lewandowski KC; Shalet SM; Lewinski A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):957-64. PubMed ID: 18031310
[TBL] [Abstract][Full Text] [Related]
18. Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer.
Cavdar Z; Canda AE; Terzi C; Sarioglu S; Fuzun M; Oktay G
Colorectal Dis; 2011 Feb; 13(2):154-60. PubMed ID: 19888958
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
[TBL] [Abstract][Full Text] [Related]
20. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]